A detailed history of Federated Hermes, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 2,397 shares of CRL stock, worth $390,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,397
Previous 44,436 94.61%
Holding current value
$390,758
Previous $8.75 Million 94.95%
% of portfolio
0.0%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$178.58 - $220.69 $7.51 Million - $9.28 Million
-42,039 Reduced 94.61%
2,397 $442,000
Q3 2024

Nov 13, 2024

SELL
$187.96 - $245.29 $884,163 - $1.15 Million
-4,704 Reduced 9.57%
44,436 $8.75 Million
Q2 2024

Aug 08, 2024

SELL
$206.39 - $268.73 $8,049 - $10,480
-39 Reduced 0.08%
49,140 $10.2 Million
Q1 2024

May 14, 2024

SELL
$203.52 - $273.43 $5.09 Million - $6.84 Million
-25,028 Reduced 33.73%
49,179 $13.3 Million
Q4 2023

Jan 31, 2024

SELL
$164.52 - $238.84 $16,287 - $23,645
-99 Reduced 0.13%
74,207 $17.5 Million
Q3 2023

Nov 13, 2023

SELL
$194.44 - $217.61 $5.85 Million - $6.54 Million
-30,066 Reduced 28.81%
74,306 $14.6 Million
Q2 2023

Aug 14, 2023

SELL
$183.71 - $210.25 $4.12 Million - $4.71 Million
-22,423 Reduced 17.68%
104,372 $21.9 Million
Q1 2023

May 08, 2023

SELL
$191.89 - $259.92 $4.46 Million - $6.04 Million
-23,233 Reduced 15.49%
126,795 $25.6 Million
Q4 2022

Feb 13, 2023

SELL
$197.11 - $250.07 $7.27 Million - $9.22 Million
-36,889 Reduced 19.74%
150,028 $32.7 Million
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $4.73 Million - $6.5 Million
-25,951 Reduced 12.19%
186,917 $36.8 Million
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $3.71 Million - $5.5 Million
18,196 Added 9.35%
212,868 $45.5 Million
Q1 2022

May 13, 2022

SELL
$255.51 - $362.11 $5.11 Million - $7.24 Million
-19,988 Reduced 9.31%
194,672 $55.3 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $5.3 Million - $6.76 Million
15,076 Added 7.55%
214,660 $80.9 Million
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $1.79 Million - $2.2 Million
4,811 Added 2.47%
199,584 $82.4 Million
Q2 2021

Aug 16, 2021

SELL
$294.17 - $371.65 $2.85 Million - $3.6 Million
-9,689 Reduced 4.74%
194,773 $72.1 Million
Q1 2021

May 13, 2021

BUY
$249.67 - $299.48 $7.27 Million - $8.73 Million
29,137 Added 16.62%
204,462 $59.3 Million
Q4 2020

Feb 12, 2021

SELL
$222.0 - $252.62 $4.98 Million - $5.66 Million
-22,415 Reduced 11.34%
175,325 $43.8 Million
Q3 2020

Nov 12, 2020

SELL
$175.56 - $226.45 $2.64 Million - $3.4 Million
-15,033 Reduced 7.07%
197,740 $44.8 Million
Q2 2020

Aug 13, 2020

SELL
$118.84 - $189.72 $1.1 Million - $1.76 Million
-9,295 Reduced 4.19%
212,773 $37.1 Million
Q1 2020

May 13, 2020

BUY
$98.9 - $178.34 $4.79 Million - $8.64 Million
48,441 Added 27.9%
222,068 $28 Million
Q4 2019

Feb 14, 2020

BUY
$126.05 - $152.76 $3.03 Million - $3.68 Million
24,067 Added 16.09%
173,627 $26.5 Million
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $3.87 Million - $4.44 Million
30,931 Added 26.07%
149,560 $19.8 Million
Q2 2019

Aug 14, 2019

BUY
$123.4 - $148.55 $1.26 Million - $1.52 Million
10,208 Added 9.42%
118,629 $16.8 Million
Q1 2019

May 10, 2019

BUY
$104.82 - $146.73 $7.85 Million - $11 Million
74,915 Added 223.59%
108,421 $15.7 Million
Q4 2018

Feb 13, 2019

BUY
$105.09 - $137.23 $1.65 Million - $2.15 Million
15,670 Added 87.86%
33,506 $3.79 Million
Q3 2018

Nov 13, 2018

SELL
$112.11 - $134.54 $476,131 - $571,391
-4,247 Reduced 19.23%
17,836 $2.4 Million
Q2 2018

Aug 10, 2018

BUY
$102.37 - $117.25 $362,082 - $414,713
3,537 Added 19.07%
22,083 $2.48 Million
Q1 2018

May 09, 2018

SELL
$98.19 - $115.2 $512,551 - $601,344
-5,220 Reduced 21.96%
18,546 $1.98 Million
Q4 2017

Feb 14, 2018

SELL
$100.43 - $118.09 $425,421 - $500,229
-4,236 Reduced 15.13%
23,766 $0
Q3 2017

Nov 13, 2017

BUY
$96.72 - $109.26 $2.71 Million - $3.06 Million
28,002
28,002 $3.03 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.29B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.